相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials
Abrar K. Thabit et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
beta-Lactam/beta-lactamase inhibitors versus carbapenems for the treatment of sepsis: systematic review and meta-analysis of randomized controlled trials
Shachaf Shiber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Clinical Experience of Colistin-Glycopeptide Combination in Critically Ill Patients Infected with Gram-Negative Bacteria
Nicola Petrosillo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
George L. Daikos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Whole-Genome Sequencing Shows That Patient-to-Patient Transmission Rarely Accounts for Acquisition of Staphylococcus aureus in an Intensive Care Unit
James R. Price et al.
CLINICAL INFECTIOUS DISEASES (2014)
The Trials and Tribulations of Treating Clostridium difficile Infection-One Step Backward, One Step Forward, but Still Progress
Mark H. Wilcox
CLINICAL INFECTIOUS DISEASES (2014)
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Jason A. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2014)
Treating infections caused by carbapenemase-producing Enterobacteriaceae
L. S. Tzouvelekis et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study
M. Giannella et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Emerging Technologies for the Clinical Microbiology Laboratory
Blake W. Buchan et al.
CLINICAL MICROBIOLOGY REVIEWS (2014)
Augmented Renal Clearance in the ICU: Results of a Multicenter Observational Study of Renal Function in Critically Ill Patients With Normal Plasma Creatinine Concentrations
Andrew A. Udy et al.
CRITICAL CARE MEDICINE (2014)
Diagnostic Microbiology and Infectious Disease
Ronald N. Jones et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)
Ceftolozane/Tazobactam: A Novel Cephalosporin/beta-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli
George G. Zhanel et al.
DRUGS (2014)
Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens
Garyphallia Poulakou et al.
FUTURE MICROBIOLOGY (2014)
What's new in antimicrobial use and resistance in critically ill patients?
Matteo Bassetti et al.
INTENSIVE CARE MEDICINE (2014)
What can be expected from antimicrobial de-escalation in the critically ill?
Marin H. Kollef
INTENSIVE CARE MEDICINE (2014)
De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study
Djamel Mokart et al.
INTENSIVE CARE MEDICINE (2014)
Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study
Mitchell M. Levy et al.
INTENSIVE CARE MEDICINE (2014)
SDD and colistin resistance: end of a dream?
Matteo Bassetti et al.
INTENSIVE CARE MEDICINE (2014)
Impact of de-escalation on ICU patients' prognosis
Jan J. De Waele et al.
INTENSIVE CARE MEDICINE (2014)
De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU
Jean-Francois Timsit et al.
INTENSIVE CARE MEDICINE (2014)
De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial
Marc Leone et al.
INTENSIVE CARE MEDICINE (2014)
Extensively drug-resistant Pseudomonas aeruginosa ventriculitis and meningitis treated with intrathecal colistin
Gul Karagoz et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria
Konstantinos Pontikis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Prolonging β-lactam infusion: A review of the rationale and evidence, and guidance for implementation
Shawn H. MacVane et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Association Between Vancomycin Minimum Inhibitory Concentration and Mortality Among Patients With Staphylococcus aureus Bloodstream Infections A Systematic Review and Meta-analysis
Andre C. Kalil et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort
L. E. Lopez-Cortes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial
Lennie P. G. Derde et al.
LANCET INFECTIOUS DISEASES (2014)
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A. Roberts et al.
LANCET INFECTIOUS DISEASES (2014)
Antibiotic Resistance - Problems, Progress, and Prospects
Carl Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection
Nicholas S. Britt et al.
INFECTIOUS DISEASES AND THERAPY (2014)
Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study
Marya D. Zilberberg et al.
CRITICAL CARE (2014)
Antibiotic stewardship in the intensive care unit
Charles-Edouard Luyt et al.
CRITICAL CARE (2014)
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
Gennaro De Pascale et al.
CRITICAL CARE (2014)
Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter
S. J. van Hal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Risk Factors for Treatment Failure of Polymyxin B Monotherapy for Carbapenem-Resistant Klebsiella pneumoniae Infections
Yanina Dubrovskaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae
Helen Giamarellou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia
Julio Ramirez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: MIC Matters
Nan-Yao Lee et al.
CLINICAL INFECTIOUS DISEASES (2013)
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
Emanuele Durante-Mangoni et al.
CLINICAL INFECTIOUS DISEASES (2013)
Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
Ana M. Sandri et al.
CLINICAL INFECTIOUS DISEASES (2013)
Can optimal drug dosing during ECMO improve outcomes?
Kiran Shekar et al.
INTENSIVE CARE MEDICINE (2013)
Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors
Ignacio Martin-Loeches et al.
INTENSIVE CARE MEDICINE (2013)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
R. P. Dellinger et al.
INTENSIVE CARE MEDICINE (2013)
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients
Mario Tumbarello et al.
INTENSIVE CARE MEDICINE (2013)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L. Silvia Munoz-Price et al.
LANCET INFECTIOUS DISEASES (2013)
Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis
Nick Daneman et al.
LANCET INFECTIOUS DISEASES (2013)
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective
Stefano Aliberti et al.
THORAX (2013)
Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock - a systematic review and meta-analysis
Anna Prkno et al.
CRITICAL CARE (2013)
Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in surgical wounds
Kurinchi Selvan Gurusamy et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients
Leslie Gonzalez et al.
CRITICAL CARE (2013)
Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
Zubair A. Qureshi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Impact of Cefepime Therapy on Mortality among Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli
Teena Chopra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Systematic review and meta-analysis of outcomes following emergency surgery for Clostridium difficile colitis
A. Bhangu et al.
BRITISH JOURNAL OF SURGERY (2012)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
Lidia Dalfino et al.
CLINICAL INFECTIOUS DISEASES (2012)
Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
Richard G. Wunderink et al.
CLINICAL INFECTIOUS DISEASES (2012)
Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
Paritosh Prasad et al.
CLINICAL INFECTIOUS DISEASES (2012)
Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli
J. Rodriguez-Bano et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Pseudomonas aeruginosa is not just in the intensive care unit any more: Implications for empirical therapy
Kathryn J. Eagye et al.
CRITICAL CARE MEDICINE (2012)
Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates
G. Samonis et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit
Keyvan Razazi et al.
INTENSIVE CARE MEDICINE (2012)
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study
Alexis Tabah et al.
INTENSIVE CARE MEDICINE (2012)
A network meta-analysis of antibiotics for treatment of hospitalised patients with suspected or proven meticillin-resistant Staphylococcus aureus infection
Michele Ballya et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe Sepsis A Randomized Trial
Frank M. Brunkhorst et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis
Konstantinos Z. Vardakas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
The crisis of no new antibiotics-what is the way forward?
Laura J. V. Piddock
LANCET INFECTIOUS DISEASES (2012)
Ten-year decrease of acquired methicillin-resistant Staphylococcus aureus (MRSA) bacteremia at a single institution: the result of a multifaceted program combining cross-transmission prevention and antimicrobial stewardship
Annie Chalfine et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2012)
Diverting Loop Ileostomy and Colonic Lavage An Alternative to Total Abdominal Colectomy for the Treatment of Severe, Complicated Clostridium difficile Associated Disease
Matthew D. Neal et al.
ANNALS OF SURGERY (2011)
Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious Disease
Yun Cai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
S. M. Garonzik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Impact of antimicrobial stewardship in critical care: a systematic review
Reham Kaki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)
Ana C. Gales et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Hand Hygiene
Yves Longtin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia
Ioannis A. Bliziotis et al.
PLOS ONE (2011)
Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis Due to Gram-Negative Bacteria: a Retrospective Analysis
Scott T. Micek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The 10 x '20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
David N. Gilbert et al.
CLINICAL INFECTIOUS DISEASES (2010)
Community-Onset Bacteremia Due to Extended-Spectrum beta-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis
Jesus Rodriguez-Bano et al.
CLINICAL INFECTIOUS DISEASES (2010)
Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis
Anand Kumar et al.
CRITICAL CARE MEDICINE (2010)
Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections
J. Floris S. Logman et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit
Miguel Sanchez Garcia et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use
M. Sundqvist et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
De-escalation after empirical meropenem treatment in the intensive care unit: Fiction or reality?
Jan J. De Waele et al.
JOURNAL OF CRITICAL CARE (2010)
Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia
Anthony M. Nicasio et al.
JOURNAL OF CRITICAL CARE (2010)
Effectiveness of Treatments for Severe Sepsis A Prospective, Multicenter, Observational Study
Ricard Ferrer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock
Anand Kumar et al.
CHEST (2009)
Intravenous Tigecycline as Adjunctive or Alternative Therapy for Severe Refractory Clostridium difficile Infection
Bjorn L. Herpers et al.
CLINICAL INFECTIOUS DISEASES (2009)
Do we still need the aminoglycosides?
Emanuele Durante-Mangoni et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Direct Identification of Bacteria in Positive Blood Culture Bottles by Matrix-Assisted Laser Desorption Ionisation Time-of-Flight Mass Spectrometry
Bernard La Scola et al.
PLOS ONE (2009)
The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America
Brad Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2008)
Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia
Daren K. Heyland et al.
CRITICAL CARE MEDICINE (2008)
Successful, multiresistant bacterial clones
Neil Woodford
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings
Jane D. Siegel et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2007)
An increasing threat in hospitals:: multidrug-resistant Acinetobacter baumannii
Lenie Dijkshoorn et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain
Francois Lamontagne et al.
ANNALS OF SURGERY (2007)
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship
Timothy H. Dellit et al.
CLINICAL INFECTIOUS DISEASES (2007)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients
K Goethaert et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Acinetobacter baumannii ventilator-associated pneumonia:: epidemiological and clinical findings
J Garnacho-Montero et al.
INTENSIVE CARE MEDICINE (2005)
beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials
M Paul et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis:: Case series and review of the literature
A Apisarnthanarak et al.
CLINICAL INFECTIOUS DISEASES (2002)
分享论文
